drugset / Trial / NCT01463371

Effects of Azithromycin on Airway Oxidative Stress Markers in Patients With Bronchiectasis

NCT01463371

RandomizedParallel-groupOpen-labelBasic science

Summary

The mechanism by which macrolide antibiotics have immune modifying effects independent from its antibacterial activity has not been well established. In the present work, the investigators will analyze the effect of long-term treatment with azithromycin (250 mg three times per week during three months) on airway oxidative stress markers in exhaled breath condensate of adult patients with stable non-CF bronchiectasis.

Timeline

Start
2006-10
Primary completion
2007-04
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azithromycin Small molecule 250 mg

Indications